Incyte Corp.

NASDAQ:INCY

68.45

+0.28 (+0.41%)

4:06:22 PM EDT: $66.00 -2.45 (-3.58%)

Market Cap (Intraday)	13.30B
Current PE	625.49
Forward PE	12.07
2yr Forward PE	10.19

See more stats

Estimates Current Quarter

Revenue	$1.15 Billion
Adjusted EPS	$1.40

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Incyte Corp. Stock, NASDAQ:INCY

1801 Augustine Cut-Off, 1801 Augustine Cut-Off, Wilmington, Delaware 19803

United States of America

Phone: +1.302.498.6700

Number of Employees: 2617

http://www.incyte.com

Description

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.